معرفی
Crawford Halliday is an Honorary Clinical Lecturer at the University of Glasgow's School of Cardiovascular & Metabolic Health. His work focuses on cardiovascular diseases, metabolic health, and advanced therapeutic strategies involving miRNA regulation and targeted drug delivery. He has contributed to studies on heart failure treatments, vascular remodeling, and gene therapy applications in cardiac medicine.
Research Interests: His primary areas of expertise include cardiac vasculature biology, miRNA dysregulation in vascular pathologies, and translational therapies for heart failure and in-stent restenosis. He employs molecular biology techniques such as phage display and genetic ablation models to develop novel treatment approaches.
Publications: His recent work explores SGLT2 inhibitors for diuretic-resistant heart failure and miRNA-based therapies for vascular diseases. Earlier research includes foundational studies on vein graft pathology and adenovirus engineering for cardiac vascular targeting.
Awards: No scientific awards explicitly listed in the provided text.
Advising & Grants: No specific advising or grant details are provided in the text.
Labs/Teams: Affiliated with cardiovascular research teams at the University of Glasgow, though specific lab names are not mentioned.